The rating reflects Moody’s Investors Services’ expectation the medical center will successfully pay the notes at or prior to their maturity on March 1, 2020, to receive the direct loan provided by the U.S. Department of Agriculture, Rural Development.
More articles on healthcare finance:
Fitch affirms ‘BBB’ rating on Humana’s senior notes
Moody’s downgrades MedStar Health’s rating to ‘Aa2’
S&P revises Massachusetts Ear and Eye’s outlook to negative
